Government involvement in the cannabis-sector is inevitable. Many canna-businesses trade on the OTC Pink marketplace, so full SEC disclosure is not required. Along with rampant underreporting, the erratic nature and volatility of the sector has triggered the halting of trading for many stocks. Also, many companies in the space are developing marijuana based pharmaceuticals, which almost guarantees required FDA testing/approval in the future. How can a company please the feds? Hire people that have worked with them.

Since early April, Creative Edge Nutrition (OTC: FITX) has been quite active (and creative) in appointing new members to their board. Since April 17th, FITX has strategically appointed three new members that have the potential to make an immediate (and long term) impact on the business.

On April 17th, John A. Germinario was appointed as the Chairman of the Board. Germinario is the CEO of Global Securities Services Corporation, and has worked extensively as a fraud examiner with the SEC and the IRS. His experience working with the SEC could go a long way in avoiding the fate of companies like Advanced Cannabis Solutions (OTC: CANN) and Growlife (OTC: PHOT).  

One week later, on April 23rd, the company announced that Dr. David L. Felten M.D., Ph. D. would be joining the board as well as their Chief Medical Director. According to the press release announcing his unanimous appointment, Felten has known the new chairman, Germinario, for almost 15 years.

Felten is a well respected doctor, with over 200 peer-reviewed publications and reviews, and serving on various medical research boards around the world. He has served on the National Board of Medical Examiners for many years, and has helped prepare questions for the US Medical Licensure Examinations. With the combination of Felten and Chief Pharmacology Officer Dr. Sam Alawieh, FITX will be ready when the FDA starts clinical trials on cannabis based pharmaceuticals.

May 8th, the company announced yet another board addition, this time coming from the financial space. Michael K. Clark is the CEO of MKC Capital Partners, and has held executive positions at major firms, including Fidelity and JP Morgan. Due to the limited access to banking and capital, Clark’s experience in the financial space could prove beneficial in securing the company’s financial future.